Moderna Reports First Profit in Two Years Amidst Pivot to Cancer Vaccines
Trendline

Moderna Reports First Profit in Two Years Amidst Pivot to Cancer Vaccines

What's Happening? Moderna has reported its first quarterly profit in two years, achieving $162 million in profit on $1.3 billion in revenue, marking a 29% increase from the previous year. This financial turnaround comes as the company pivots its focus from its initial success with COVID-19 vaccines
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.